OTC Skincare in Tubes: What Brands Need to Plan

A tube of sunscreen and a tube of moisturizer may look similar, but the work behind them can be different. If your product is an over-the-counter drug in the United States, the formula, claims, manufacturing, testing, and label all need to fit that route to market.

Settle those questions before ordering printed tubes or committing to a launch date. Use this guide to prepare the discussion with your manufacturer and regulatory reviewer.

Is the product a cosmetic, a drug, or both?

Classification depends on intended use, which can be established by claims and other evidence. An ingredient name alone is not a complete classification rule. For example, a product marketed to treat acne is different from one marketed only to cleanse or improve appearance. A moisturizer with sunscreen claims can be both a cosmetic and a drug. FDA’s cosmetic and drug guidance

Bring the proposed label, website claims, formula, and directions to the review. Ask the reviewer to identify what needs to change before those claims appear on packaging or sales materials.

What does an OTC monograph cover?

FDA describes two main routes for nonprescription drugs: a drug application and the OTC monograph process. A monograph sets conditions such as active ingredients, uses, doses, routes, labeling, and testing. A product may be marketed without an approved drug application only when it meets the applicable legal requirements. FDA’s OTC monograph overview

Ask which current monograph and orders apply to your proposed product. Confirm the formula, dosage form, claims, and directions against those requirements. The fact that a similar product is sold online is not enough to establish the route for yours.

For the current documents, use OTC Monographs@FDA. It distinguishes proposed and final administrative orders; those statuses matter when a requirement is changing.

What should you check about the manufacturer?

Ask about the specific OTC category you want to produce, the site that will make it, and the work performed there. Drug manufacturing is subject to current good manufacturing practice requirements, including the framework in 21 CFR Parts 210 and 211. FDA’s drug CGMP overview

Registration and product listing are separate from approval. FDA explicitly states that registration or listing does not mean an establishment or product is approved. FDA’s explanation of approval claims

Useful questions for a first discussion include:

• What experience do you have with this product category and package?
• Who reviews the formula, claims, and labeling requirements?
• Which tests are performed in-house and which are sent to a laboratory?
• How are deviations investigated, and how will we be informed?
• What documents can we review during supplier qualification?

Who is responsible for what?

Write down the responsibilities rather than assuming “turnkey” covers everything. FDA’s guidance on drug contract manufacturing recommends quality agreements that define the parties’ manufacturing activities and how they will communicate. Outsourcing an activity does not remove the parties’ applicable CGMP responsibilities. FDA guidance on quality agreements

Use the following questions to make that discussion concrete.

Make room for the Drug Facts label

OTC labels generally use the Drug Facts format. The rules specify content and presentation, including active ingredients, purpose, uses, warnings, directions, other information, and inactive ingredients. Have the final layout reviewed against the requirements that apply to the product. 21 CFR 201.66: OTC labeling

Ask for that review before printing. A small tube or an additional claim can affect how much space the label needs. Supply the actual package drawing and proposed text, not just a design mockup with placeholder copy.

How should testing affect the schedule?

Ask the quality and regulatory team what data the product needs and how the proposed expiration date will be supported. FDA explains the role of stability data in drug expiration dating. FDA’s expiration-date questions and answers

Get a project-specific schedule showing formula work, package selection, testing, artwork, production, and release. Ask what can run in parallel and what depends on an earlier result. A fixed number of weeks in a general article cannot tell you when your product will be ready.

If the formula, package, supplier, or manufacturing site changes, ask how the change will be assessed and what additional work is needed. Avoid assuming either that all existing data transfers or that everything must automatically restart.

Prepare for the first conversation

Send the product concept or existing formula, intended claims, package size, available test reports, expected volume, and target launch date. If you already have a regulatory assessment, include it.

InSpec manufactures OTC topical products and offers tube filling. Tell us about the product you plan to launch to discuss the manufacturing work and the information needed to evaluate it.